Clinical Trial Update: Post Marketing Surveillance to Monitor the Safety and Efficacy of Metalyse® in Korean Patients With Acute Myocardial Infarction

View source ↗

Summary

A completed post-marketing surveillance study in Korean patients assessed the safety and efficacy of Metalyse (tenecteplase) for acute myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Metalyse (tenecteplase)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Myocardial Infarction | Status: COMPLETED